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Significant changes are occurring in the landscape of abortion provision in the UK. More women are 
having medical abortions and self-managing these at home, resulting in an increase in the 
proportion of abortions performed before 10 weeks’ gestation.[1]. Since 2018, women in Britain 
have been able to take misoprostol, the second medication for medical abortion, at home provided 
they have attended a clinic to have it prescribed.  The COVID pandemic has accelerated the trend 
towards self-management. As an emergency and temporary measure due to concerns about 
reduced health service access for women with unwanted pregnancies during the pandemic, 
consultations about pregnancy options have occurred by telephone or video and, if women wish and 
are deemed clinically appropriate, a medical abortion pack of both mifepristone and misoprostol can 
be posted to their home (up to nine weeks, six days gestation in England and Wales, and no 
restriction in Scotland, but clinical guidelines state up to 11 weeks, six days). Laws prohibiting 
abortion have been repealed in Northern Ireland, effectively decriminalising most abortions, and 
pressure for decriminalisation has been mounting in the rest of the UK. The changes are taking place 
alongside shifts in thinking about healthcare generally. Recognition of patient-centred approaches 
and supported self-management, alongside enhancement of activities that complement clinical care 
in sexual and reproductive health, has gained more prominence.  
The changes have significant implications for all methods of abortion delivery and care. The roles and 
scope of non-abortion specialist healthcare practitioners, such as pharmacists, general practitioners 
(GPs), nurses and midwives, in administering and supporting abortion procedures (including medical 
abortion and vacuum aspiration) are being reconsidered. The location and staffing of abortion 
services has a major role in normalising abortion and removing stigma.  Abortion is a common 
procedure, but its “separateness” can isolate it from mainstream services and marginalise those 
providing abortion services. Changes to the legal framework of abortion provision alone will remove 
some, but not all, barriers to access - for either women or practitioners. Where decriminalisation has 
occurred elsewhere, as in Australia, stigma and negative attitudes toward abortion among some 
health practitioners have persisted.[2] A GP survey in Northern Ireland examining the effect of 
recent decriminalisation found only around 40% felt abortion services should be part of general 
practice, and only half would be willing to prescribe abortion pills.[3] No relevant data are available 
on the inclination of healthcare practitioners in other parts of the UK to expand their role in abortion 
provision. In Canada, however, where training has been provided, more doctors have been willing to 
undertake abortions.[4] Medical abortion delivery and care provided by nurses, midwives and 
pharmacists have been found to be effective, safe and acceptable to women. Evidence from low and 
middle income countries, where task-shifting and sharing is more widespread, illustrates trained 
nurses and midwives can safely and effectively provide vacuum aspirations,[5] and within NHS early 
pregnancy units, nurses have long performed the same procedure where pregnancy is non-viable.  In 
UK primary care, the development of new clinical roles such as Advanced Clinical Practitioners and 
General Practice Assistants, provide expanded opportunities for multidisciplinary service provision. A 
systematic review has highlighted lessons to be learnt about abortion provision in these settings for 
the UK context.[6] While rates of effectiveness and safety outcomes were comparable between 
specialist and non-specialist abortion providers, job satisfaction increased amongst midwives and 
nurses and abortion specialists were freer to manage more complex cases. However, potential 
negative consequences of transferring more early medical abortion to primary care settings included 
the imposition of a greater burden on GPs and longer patient waiting times.   
Self and home administration of medications for abortion are effective and acceptable for women, 
for many even preferable particularly where decision-making is made jointly with the healthcare 
provider.[7]  Telemedicine consultations for those having early medical abortions at home have also 
been reported to be safe, acceptable and effective.[8] Additional benefits include reduced waiting 
times and gestation age at abortion and greater privacy and convenience for many patients. Yet, the 
appropriate balance of e-health delivery and face-to-face contact clearly depends on context and 
patient preference.  
A consultation conducted by the Scottish Government in June 2021 on continuing permission for 
mifepristone at home found much of the opposition was driven by pro-life campaigners and faith 
groups.[9] For the benefits of recent trends to be enhanced, and any costs diminished, a robust 
evidence-base is needed to inform and underpin programmatic action and policy. Evidence 
necessary to understand and support workforce willingness and preparedness for changes in 
abortion care and provision in the UK is scant. Provider education for non-abortion specialist 
healthcare practitioners is not yet in place in the UK and little is known about the level of training 
required and what the demand would be. Research is needed on optimal ways of increasing non-
specialist practitioner confidence and competence to support women both in face-to-face and 
remote consultations with self- and home management and to understand potential barriers, such 
as concerns around financing and medicolegal factors.  
The SACHA (Shaping Abortion for Change) Study, funded by the National Institute for Health 
Research, aims to provide an evidence-base to inform optimal configuration of health services and 
systems for abortion provision in the UK. We will collate and synthesise existing research findings on 
novel models of care, draw lessons from countries spearheading reforms in abortion provision, and 
consult women, practitioners and key stakeholders on approaches likely to be most feasible and 
acceptable in the UK context. An important component of this work is a national survey to assess 
healthcare practitioners’ views on the desirability and perceived consequences of decriminalisation 
and demedicalisation of abortion. A comprehensive understanding of UK healthcare practitioners’ 
attitudes, current practices and future intentions will help identify and address challenges and 
opportunities for future provision of high-quality abortion care. The COVID pandemic has acted as a 
catalyst to innovation in some European countries, but in others inequalities in abortion access have 
widened.[10] The SACHA Study is timely and will provide essential evidence for future abortion 
provision in the UK and elsewhere.   
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